While the studys findings are limited by the specific demographics of Reddit, highlighting younger American males, the side effects reported by this group align closely with established clinical data for semaglutide and tirzepatide
Results vary by individual, but many patients observe measurable weight reduction within 812 weeks when semaglutide or tirzepatide is combined with consistent lifestyle support
Compared with those who didn't take GLP-1s, those who did had a reduction of 10% to 20% in heart failure, cardiac arrest, lung failure, and pneumonia, and Alzheimer's disease and other types of dementia
Dinh QN, Chrissobolis S, Diep H, Chan CT, Ferens D, Drummond GR, et al
A recent cross-sectional study involving 124 participants indicated that 56% of patients still exhibited elevated residual gastric contents despite halting incretin agonists for a minimum of 7 days, thus challenging the practice of discontinuing long-acting GLP-1 RAs solely for this duration prior to surgery [19]
Thats why a real medical screening is always required before starting
